Ran Geng

Ran Geng is a board member at Chameleon Biosciences. Ran was previously a vice president at OrbiMed and Matrix Partners. Ran has also worked as an angel investor and associate consultant.

Ran Geng has over 10 years of experience in the life sciences industry. Ran has a proven track record of sourcing and leading investments in innovative companies. Ran has also played a key role in incubating new companies.

Ran Geng’s experience spans across various therapeutic areas including oncology, immunology, and gene therapy. Ran has a deep understanding of the Chinese life sciences market and has led several successful investments in China-based companies.

Ran Geng is a passionate advocate for the advancement of life sciences and healthcare. Ran is committed to supporting early-stage companies that are working on breakthrough therapies that can improve the lives of patients.

Ran Geng is currently a MS candidate in Biomedical Informatics at Stanford University School of Medicine. Prior to that, they graduated from University of Pennsylvania - The Wharton School with a BSE in Operations and Management. Ran also completed a Pre-Medicine, BA in Computational Biology at University of Pennsylvania. Ran Geng was also admitted to Peking University's 8-Year M.D. Program.